RU94031161A - PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS OBTAINING, METHOD FOR TREATING DISORDERS DEVELOPING DUE TO NEURODEGENERATIVE PROCESSES - Google Patents
PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS OBTAINING, METHOD FOR TREATING DISORDERS DEVELOPING DUE TO NEURODEGENERATIVE PROCESSESInfo
- Publication number
- RU94031161A RU94031161A RU94031161/14A RU94031161A RU94031161A RU 94031161 A RU94031161 A RU 94031161A RU 94031161/14 A RU94031161/14 A RU 94031161/14A RU 94031161 A RU94031161 A RU 94031161A RU 94031161 A RU94031161 A RU 94031161A
- Authority
- RU
- Russia
- Prior art keywords
- obtaining
- pharmaceutical composition
- treating disorders
- neurodegenerative processes
- developing due
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims 2
- 201000010099 disease Diseases 0.000 title 1
- 230000000626 neurodegenerative Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 claims 3
- 238000010521 absorption reaction Methods 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 239000003112 inhibitor Substances 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 239000002899 monoamine oxidase inhibitor Substances 0.000 claims 2
- JWKWLVBSFDLSQQ-UHFFFAOYSA-N C1(=CC=CC=C1)C(C)(C)N(C)CCC Chemical compound C1(=CC=CC=C1)C(C)(C)N(C)CCC JWKWLVBSFDLSQQ-UHFFFAOYSA-N 0.000 claims 1
- -1 N- (4-fluorophenyl) -isoprop-1-yl-N-methylpropylamine Chemical compound 0.000 claims 1
- 206010053643 Neurodegenerative disease Diseases 0.000 claims 1
- 239000002207 metabolite Substances 0.000 claims 1
- 239000000546 pharmaceutic aid Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
Claims (1)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU4060/91 | 1991-12-20 | ||
HU914060A HUT63579A (en) | 1991-12-20 | 1991-12-20 | Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes |
PCT/HU1992/000060 WO1993012775A1 (en) | 1991-12-20 | 1992-12-18 | Pharmaceutical composition and process for the preparation thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
RU94031161A true RU94031161A (en) | 1996-03-27 |
RU2125448C1 RU2125448C1 (en) | 1999-01-27 |
Family
ID=10966728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU94031161A RU2125448C1 (en) | 1991-12-20 | 1992-12-18 | Pharmaceutical composition and a method of its preparing, method of treatment of disorders caused by neurodegenerative processes |
Country Status (27)
Country | Link |
---|---|
US (1) | US5589513A (en) |
EP (1) | EP0617615A1 (en) |
JP (1) | JPH07502730A (en) |
KR (1) | KR940703655A (en) |
AU (1) | AU677170B2 (en) |
BG (1) | BG98827A (en) |
BR (1) | BR9206950A (en) |
CA (1) | CA2125776A1 (en) |
CZ (1) | CZ147494A3 (en) |
EC (1) | ECSP930933A (en) |
EE (1) | EE03015B1 (en) |
FI (1) | FI942932A (en) |
HU (2) | HUT63579A (en) |
IL (1) | IL104150A (en) |
LT (1) | LT3119B (en) |
LV (1) | LV10386B (en) |
MY (1) | MY111055A (en) |
NO (1) | NO942303D0 (en) |
NZ (1) | NZ246384A (en) |
PH (1) | PH31073A (en) |
PL (1) | PL172048B1 (en) |
RO (1) | RO115785B1 (en) |
RU (1) | RU2125448C1 (en) |
SI (1) | SI9200404A (en) |
SK (1) | SK74494A3 (en) |
WO (1) | WO1993012775A1 (en) |
ZA (1) | ZA929883B (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5844003A (en) * | 1991-04-04 | 1998-12-01 | Innovations Foundation | Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function |
US5817336A (en) * | 1993-04-02 | 1998-10-06 | Orion-Yhtyma Oy | Composition containing selegiline |
DE4432610C1 (en) * | 1994-09-13 | 1996-02-01 | Knoll Ag | Process for the preparation of selegiline hydrochloride |
JPH10513455A (en) | 1995-02-10 | 1998-12-22 | ザ ユニバーシティ オブ トロント イノベーションズ ファウンデーション | Deprenyl compounds for the treatment of glaucoma |
JP4499208B2 (en) | 1998-10-29 | 2010-07-07 | 株式会社フジモト・コーポレーション | Novel optically active aminopentane derivatives |
US7374779B2 (en) * | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
HUP9902482A2 (en) * | 1999-07-22 | 2002-04-29 | Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. | Use of p-fluoro-selegiline for producing neuroprotective pharmaceutical compositions |
EP2053033A1 (en) * | 2007-10-26 | 2009-04-29 | Bayer Schering Pharma AG | Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors |
US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
DE102009045056A1 (en) * | 2009-09-28 | 2011-03-31 | Henkel Ag & Co. Kgaa | Spotting preparations |
US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
WO2016033549A2 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
WO2016033556A1 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS |
US20180147215A1 (en) | 2016-11-28 | 2018-05-31 | Lipocine Inc. | Oral testosterone undecanoate therapy |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1227447B (en) * | 1962-03-30 | 1966-10-27 | Chinoin Gyogyszer Es Vegyeszet | Process for the preparation of phenylisopropylamines |
HU193662B (en) * | 1983-12-20 | 1987-11-30 | Chinoin Gyogyszer Es Vegyeszet | Process for producing synergetic pharmaceutical composition of antidepressive aktivity |
HU207282B (en) * | 1984-05-31 | 1993-03-29 | Chinoin Gyogyszer Es Vegyeszet | Process for producing phenyl-alkyl-amine derivatives and pharmaceutical compositions containing them |
DE3764144D1 (en) * | 1986-04-16 | 1990-09-13 | Asta Pharma Ag | SYNERGISTIC COMBINATION OF AMANTADINE AND SELEGILINE. |
HU207280B (en) * | 1986-09-25 | 1993-03-29 | Chinoin Gyogyszer Es Vegyeszet | Process for producing new phenyl-alkyl-amines and pharmaceutical compositions containing them |
HU197510B (en) * | 1986-12-19 | 1989-04-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing pharmaceutical composition containing phenyl-alkyl-amine derivatives, against motion-sick |
US4861800A (en) * | 1987-08-18 | 1989-08-29 | Buyske Donald A | Method for administering the drug deprenyl so as to minimize the danger of side effects |
GB8807504D0 (en) * | 1988-03-29 | 1988-05-05 | Sandoz Ltd | Improvements in/relating to organic compounds |
HU208484B (en) * | 1988-08-17 | 1993-11-29 | Chinoin Gyogyszer Es Vegyeszet | Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia |
CA2037178A1 (en) * | 1990-02-28 | 1991-08-29 | Albert Walter Brzeczko | Deprenyl/l-dopa/carbidopa pharmaceutical composition |
GB9011767D0 (en) * | 1990-05-25 | 1990-07-18 | Britannia Pharmaceuticals Ltd | Pharmaceutical compositions |
US5169868A (en) * | 1991-03-01 | 1992-12-08 | University Of Saskatchewan | Aliphatic propargylamines as specific mao-b inhibitors |
US5444095A (en) * | 1991-04-04 | 1995-08-22 | University Of Toronto, Innovations Foundation | Use of deprenyl to rescue damaged nerve cells |
HU209605B (en) * | 1991-04-15 | 1994-09-28 | Chinoin Gyogyszer Es Vegyeszet | Process for production of wather-free transdermal preparation |
US5326770A (en) * | 1992-07-17 | 1994-07-05 | The Du Pont Merck Pharmaceutical Company | Monoamine oxidase-B (MAO-B) inhibitory 5-substituted 2,4-thiazolidinediones useful in treating memory disorders of mammals |
-
1991
- 1991-12-20 HU HU914060A patent/HUT63579A/en unknown
-
1992
- 1992-12-18 BR BR9206950A patent/BR9206950A/en not_active Application Discontinuation
- 1992-12-18 WO PCT/HU1992/000060 patent/WO1993012775A1/en not_active Application Discontinuation
- 1992-12-18 AU AU32652/93A patent/AU677170B2/en not_active Ceased
- 1992-12-18 RO RO94-01015A patent/RO115785B1/en unknown
- 1992-12-18 KR KR1019940702143A patent/KR940703655A/en active IP Right Grant
- 1992-12-18 CA CA002125776A patent/CA2125776A1/en not_active Abandoned
- 1992-12-18 NZ NZ246384A patent/NZ246384A/en unknown
- 1992-12-18 MY MYPI92002341A patent/MY111055A/en unknown
- 1992-12-18 SK SK744-94A patent/SK74494A3/en unknown
- 1992-12-18 PL PL92304116A patent/PL172048B1/en unknown
- 1992-12-18 JP JP5510411A patent/JPH07502730A/en active Pending
- 1992-12-18 CZ CZ941474A patent/CZ147494A3/en unknown
- 1992-12-18 US US08/256,128 patent/US5589513A/en not_active Expired - Fee Related
- 1992-12-18 SI SI9200404A patent/SI9200404A/en unknown
- 1992-12-18 ZA ZA929883A patent/ZA929883B/en unknown
- 1992-12-18 IL IL104150A patent/IL104150A/en not_active IP Right Cessation
- 1992-12-18 RU RU94031161A patent/RU2125448C1/en active
- 1992-12-18 EP EP93901880A patent/EP0617615A1/en not_active Withdrawn
- 1992-12-18 PH PH45474A patent/PH31073A/en unknown
- 1992-12-20 LV LVP-92-547A patent/LV10386B/en unknown
- 1992-12-21 LT LTIP249A patent/LT3119B/en not_active IP Right Cessation
-
1993
- 1993-05-25 EC EC1993000933A patent/ECSP930933A/en unknown
-
1994
- 1994-06-02 BG BG98827A patent/BG98827A/en unknown
- 1994-06-17 NO NO942303A patent/NO942303D0/en unknown
- 1994-06-17 FI FI942932A patent/FI942932A/en unknown
- 1994-08-10 EE EE9400117A patent/EE03015B1/en unknown
-
1995
- 1995-06-16 HU HU95P/P00218P patent/HU211478A9/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU94031161A (en) | PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS OBTAINING, METHOD FOR TREATING DISORDERS DEVELOPING DUE TO NEURODEGENERATIVE PROCESSES | |
NO961687D0 (en) | New (R) -5-carbamoyl-8-fluoro-3-N, N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans | |
DK0495776T3 (en) | Stabilizing nitric oxide / primary amine complexes useful as cardiovascular agents | |
DE3484573D1 (en) | PENETRIC TOPICAL PHARMACEUTICAL COMPOSITIONS CONTAINING N- (2-HYDROXYETHYL) -PYRROLIDONE. | |
DE60126980D1 (en) | THERAPEUTIC AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AMYLOIDOGENIC ILLNESSES | |
MX9100990A (en) | MOMETASONE FUROATE MONOHYDRATE COMPOUND, THE PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS | |
BR9406979A (en) | Compound, pharmaceutical composition for treating an inflammatory disease susceptible to treatment with a non-steroidal anti-inflammatory agent processes for treating an inflammatory disease and for preparing a pharmaceutically acceptable salt compound use of a non-steroidal anti-inflammatory pharmaceutical composition compound | |
DE122009000012I1 (en) | Substituted pyrazolylbenzenesulfonamides for the treatment of inflammation. | |
DE69716810D1 (en) | 2,3-disubstituted-(5,6) -heteroarylkondensierte-pyrimidin-4-one | |
BR9507073A (en) | Composed processes to prepare the same and to treat a disease in the central nervous system pharmaceutical composition and use of the compound | |
ES2136252T3 (en) | TREATMENT OF DISEASES CAUSED BY SEBACEA GLAND DISORDERS THROUGH THE USE OF ACIL COA CHOLESTEROL ACIL TRANSFERASE INHIBITORS. | |
BG98827A (en) | Pharmaceutical composition and method for its preparation | |
MX24839A (en) | 3-ARYCARBONYL-1-AMINOALKYL-1H-INDOLES, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION WHICH IT CONTAINS. | |
NO983530L (en) | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents | |
DK1032556T3 (en) | Pharmaceutically active compounds and methods of use | |
RU93053905A (en) | OXYPURINE NUCLEOSIDES AND RELATED COMPOUNDS THEREOF, AND ALSO THEIR Acyl DERIVATIVES TO IMPROVE HEMOPOESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT AND / OR PREVENTION | |
EA199800717A1 (en) | METHOD FOR THE TREATMENT OF MAMMAL DISEASES AND THE CYVITTERION COMPOSITION | |
DK0634396T3 (en) | Amino acid derivatives and their use as single phalinase inhibitors | |
DE69808475D1 (en) | AMINO ACID DERIVATIVES FOR TREATING STROKE | |
ATE48759T1 (en) | TREATMENT OF ATTACKS AND USEFUL PHARMACEUTICAL COMPOSITIONS THEREOF. | |
NO970573L (en) | Yliden compounds and their preparation | |
DE3380923D1 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISORDERS CONDITIONED BY HUMAN DRUGS. | |
ATE110714T1 (en) | HYDROXAMIC ACID DERIVATIVES WHICH INHIBIT LIPOXYGENASE. | |
ES2054790T3 (en) | COMPOUNDS THAT HAVE CARDIOVASCULAR ACTIVITY. | |
SE8402199D0 (en) | PHARMACEUTICAL PREPARATION CONTAINING CO-DERGOCRINE AND ONE CALCIUM ANTAGONISTS |